In Vitro Activities of Ceftazidime-Avibactam and Comparator Agents Against Enterobacterales and Pseudomonas aeruginosa Collected in Turkey and the Middle East: ATLAS Global Surveillance Program 2018-2022

BACKGROUND: Avibactam (AVI) is a non-β-lactam β-lactamase inhibitor that when combined with the β-lactam ceftazidime (CAZ) has demonstrated activity against Class A, Class C and some Class D enzymes. This study evaluated the in vitro activity of CAZ-AVI against Enterobacterales and Pseudomonas aerug...

Full description

Saved in:
Bibliographic Details
Main Authors: Meredith Hackel, Gregory Stone, Katherine Perez, Daniel Sahm
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716524002145
Tags: Add Tag
No Tags, Be the first to tag this record!